[Asia Economy Reporter Minji Lee] ST Pharm announced on the 28th that it recorded an operating profit of 4.875 billion KRW in the second quarter, turning to a profit. Sales grew by 19.5% to 40.4 billion KRW, and net profit increased by 124% to 5.6 billion KRW.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing